Safety and Efficacy Study of Ceftolozane/Tazobactam to Treat Ventilated Nosocomial Pneumonia (MK-7625A-008)

Conditions

• Healthcare-Associated Pneumonia
• Ventilator-Associated Pneumonia
• Lung Diseases

Interventions

• DRUG: Ceftolozane/tazobactam
• DRUG: Meropenem

Sponsor

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)